SB 241
|
Degree of Association: Identical |
|
Author: Perry
|
|
Last Action: 05/27/2023 E Effective on . . . . . . . . . . . . . . . |
|
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability. |
|